Abstract
This study focuses on the photoluminescence properties of loracarbef (LOR) ligand and its [Zn(LOR) (H2O)(Cl)]Cl, [Cd(LOR)(H2O)(Cl)]Cl, [Ni(LOR)(H2O)(Cl)]Cl, [Pd(LOR)(H2O)(AcO)]AcO and [Pt(LOR)(H2O)(Cl)]Cl complexes. LOR and the resulting metal complexes gave an intense emission (where λmax = 376 nm) upon irradiation by Ultra-Violet light. The photoluminescence quantum yields and long excited-state lifetimes of the ligand and its complexes were calculated. The LOR ligand has a photoluminescence quantum yield of 52% and long excited-state lifetime of 4.88 ns. The photoluminescence intensities and quantum yields of the metal complexes dramatically reduced with respect to that of the LOR ligand upon complexation with various metals. The structures of new complexes were characterized using spectroscopic techniques including FT-IR, electronic spectra, 1H-NMR and mass spectral data. In addition, all complexes were screened for antibacterial activity against several bacteria and yeasts, and results were compared with those of LOR.
Keywords: Loracarbef, Metal complex, Photoluminescence, Antimicrobial activity
Current Analytical Chemistry
Title: Preparation, Photoluminescence and Antimicrobial Activity of Loracarbef and its Various Complexes
Volume: 5 Issue: 4
Author(s): Huseyin Zengin, Mustafa Dolaz and Aysegul Golcu
Affiliation:
Keywords: Loracarbef, Metal complex, Photoluminescence, Antimicrobial activity
Abstract: This study focuses on the photoluminescence properties of loracarbef (LOR) ligand and its [Zn(LOR) (H2O)(Cl)]Cl, [Cd(LOR)(H2O)(Cl)]Cl, [Ni(LOR)(H2O)(Cl)]Cl, [Pd(LOR)(H2O)(AcO)]AcO and [Pt(LOR)(H2O)(Cl)]Cl complexes. LOR and the resulting metal complexes gave an intense emission (where λmax = 376 nm) upon irradiation by Ultra-Violet light. The photoluminescence quantum yields and long excited-state lifetimes of the ligand and its complexes were calculated. The LOR ligand has a photoluminescence quantum yield of 52% and long excited-state lifetime of 4.88 ns. The photoluminescence intensities and quantum yields of the metal complexes dramatically reduced with respect to that of the LOR ligand upon complexation with various metals. The structures of new complexes were characterized using spectroscopic techniques including FT-IR, electronic spectra, 1H-NMR and mass spectral data. In addition, all complexes were screened for antibacterial activity against several bacteria and yeasts, and results were compared with those of LOR.
Export Options
About this article
Cite this article as:
Zengin Huseyin, Dolaz Mustafa and Golcu Aysegul, Preparation, Photoluminescence and Antimicrobial Activity of Loracarbef and its Various Complexes, Current Analytical Chemistry 2009; 5(4) . https://dx.doi.org/10.2174/157341109789077777
DOI https://dx.doi.org/10.2174/157341109789077777 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Clinical Vignettes: Integrated Care of Cancer Patients by Oncologists and Cardiologists
Current Cardiology Reviews Editorial (Thematic Issue: Exploring the Role of Polysaccharides in Drug Delivery)
Current Pharmaceutical Design Wnt Signaling in Renal Cancer
Current Drug Targets NMR Structural Studies of Oligosaccharides Related to Cancer Processes
Anti-Cancer Agents in Medicinal Chemistry The Antibiotic Effects of Vitamin D
Endocrine, Metabolic & Immune Disorders - Drug Targets MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Current Pharmaceutical Design Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Titanium Tetrachloride-mediated Synthesis of Diarylmethanes through the Reaction of Benzyl Alcohol Derivatives with Aromatic Substrates
Current Organic Chemistry Immunotherapy for Alzheimers Disease: Rational Basis in Ongoing Clinical Trials
Current Pharmaceutical Design Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review
Current Drug Targets Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer
Current Pharmaceutical Design The ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) Trial: A Step Forward in the Treatment of Early Breast Cancer
Reviews on Recent Clinical Trials Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Advances in Lentiviral Vectors: A Patent Review
Recent Patents on DNA & Gene Sequences Cytotoxic Effect of the Combination of Gemcitabine and Atorvastatin Loaded in Nanoparticle on the MCF-7 Breast Cancer Cells and HFS Human Foreskin Cells
Current Nanoscience A Discussion of MicroRNAs in Cancers
Current Bioinformatics G and C Iterons and Strings in MicroRNAs Should be Important in Regulation of mRNAs<sup>†</sup>
MicroRNA The Role of Inflammatory Response in Stroke Associated Programmed Cell Death
Current Neuropharmacology Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Combination of Valproic Acid and ATRA Restores RARβ2 Expression and Induces Differentiation in Cervical Cancer through the PI3K/Akt Pathway
Current Molecular Medicine